<DOC>
	<DOCNO>NCT00399802</DOCNO>
	<brief_summary>This 4-week study examine effect new experimental medication woman breast cancer establish bone metastasis . This study enroll approximately 45 woman .</brief_summary>
	<brief_title>A Study Examine Effects Experimental Drug Women With Breast Cancer Metastatic Bone Disease ( MBD ) ( 0822-016 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Patient histologically cytologicallyconfirmed breast cancer Patient document skeletal metastasis Patient undergo current oral bisphosphonate therapy , history oral bisphosphonate use within 6 month entry study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>